У нас вы можете посмотреть бесплатно NATCO Pharma Semaglutide CDSCO Approval - Will the stock Revive again to 1500 levels? или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
Natco receives approval from the Central Drugs Standard Control Organisation (CDSCO) to manufacture and market generic Semaglutide injections in India on Feb 14, 2026. The stock surged by 11% on Feb 16, 2026 based on this news but is this the start of the new rally for the stock? NATCO's stock crashed 50%+ from Sep 2024-2025. Why? We dive into its Revlimid success, patent expiry woes, and recovery plan. Compare with Novo Nordisk's fall and get investor tips! Key Points discussed: NATCO: Pharma giant, 85% revenue from US exports. Revlimid: Cancer drug boosted sales from ₹2,000 Cr to ₹4,000 Cr, but patent expiry (Jan 2026) tanked Q3 FY25 sales to ₹475 Cr. Novo Nordisk: Similar drop with Ozempic/Wegovy. Future: Semaglutide, Risdiplam, 15 new drugs in pipeline. Timestamps: 0:00 - Introduction to CDSCO's Semaglutide approval for NATCO Pharma 01:43 Understanding NATCO’s Business Model 02:55 Revlimid’s Sales Growth and Decline 03:50 The story behind GRevlimid and bumper sales numbers 05:47 - Will Natco Pharma stock go up in future? **Disclaimer**: I am not SEBI registered. This video is for educational purposes only and not financial investment advice. Subscribe for more stock insights! Are you holding NATCO? #stockmarketindia #natcopharma #semaglutide #wegovyweightloss #semaglutideweightloss #wegovy Tags: Natco Pharma share price Natco Pharma stock analysis 2026 Natco Pharma Semaglutide approval Semaglutide CDSCO approval India Natco generic Ozempic launch Natco Pharma Q3 results 2026 Natco Pharma target price 2026 Natco Pharma technical analysis Best pharma stocks to buy in India Natco Pharma share latest news today Natco Pharma stock analysis in detail Natco generic Semaglutide approval explained Natco Pharma 1600 to 800 turnaround story Will Natco Pharma stock double from current levels? GLP-1 opportunity Natco Pharma vs Sun Pharma vs Dr Reddy Semaglutide Natco Pharma Q3 results analysis 2026 Natco Pharma share kyu badh raha hai? Natco Pharma me kya kare buy ya sell? Natco weight loss injection kya hai? Natco Pharma share target price 2026 hindi Natco Pharma Semaglutide news hindi Natco Pharma multibagger banega kya? Natco Pharma ka naya drug CDSCO approval Natco stock girne ke baad ab kya hoga?